|
Webinar Abstract
Title : A Novel Automated System for Buffer Exchange and Concentration of Biopharmaceuticals: Can an Automated Workflow Provide Comparable Results? Date: Thursday, 28th January 2016 Time: 16:00 GMT (Greenwich Mean Time) Is your formulation process hindered by manual processes such as buffer preparation and buffer exchange? Could you formulate faster and better if you could automate this process? With R&D expenses continuing to rise, being able to save time and develop better formulations faster is a necessity. This webinar will present a case study on Freeslate’s FormPrep system, a novel system that automates buffer preparation, buffer exchange, and the concentration of proteins. This case study will evaluate protein stability across multiple buffer exchange techniques to determine if an automated system can provide comparable results to manual methods. Russell Burge, Ph.D., Applications Scientist at Freeslate will demonstrate how the FormPrep system eliminates time consuming processes in protein preparation. FormPrep can produce 12 protein formulations in a single day, reducing the bottleneck challenge inherent in the formulation process. Join this FREE webinar with Freeslate to learn more about the FormPrep system. Discover the benefits to your protein formulation preparation processes by saving time, reducing costs, and improving quality. Key Session Highlights · Meet Freeslate’s FormPrep system · Learn how to apply this system to your protein formulation preparation · Compare FormPrep performance with existing processes · Uncover the benefits of automated protein formulation preparation The Freeslate FormPrep system is changing the way formulation processes operate, providing a practical solution to lengthy, manual processes. This webinar tells you all you need to know.
Presented By
Russell Burge Applications Scientist Freeslate Russell Burge received his Ph.D. in molecular biology and biochemistry from The Scripps Research Institute in La Jolla, California. Following this Russell later received post-doctoral training at the University of Colorado, Boulder. He has worked on the biophysical characterization of RNA and DNA aptamers relevant to the biopharmaceutical industry.
In Association with:
Produced by
Frequently Asked Questions
|